Ayaka Yanagida

Assistant Professor

University of Tokyo
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2026

Sox17 is a key transcriptional regulator of endoderm formation and function in the gallbladder, blood vessels and reproductive organs. Although multiple transcript variants of Sox17 have been suggested, the precise mechanisms underlying their time‐ and tissue‐specific expression remain unclear. In this study, we discovered two putative regulatory sequences (R1 and R2) adjacent to different transcription start sites of mouse Sox17 exon 1 and generated deletion mice for these regions ( Sox17 Δdr/Δdr ) . Sox17 Δdr/Δdr mice were alive and fertile, and they possessed a normal‐sized gallbladder. However, semiquantitative analysis of immunostaining showed that the expression levels of SOX17 in Sox17 Δdr/Δdr embryos were reduced to less than 50% of the wild‐type in the gallbladder epithelium. Furthermore, the bile ductal epithelium marker SOX9 was abnormally upregulated, and PAS/DBA‐positive mucin secretion‐like epithelial cells were induced in the Sox17 Δdr/Δdr gallbladder. Our results demonstrate that the distal sequence of Sox17 , including R1 and R2, is important for the regulation of Sox17 gene expression in the embryonic gallbladder and is crucial for normal gallbladder epithelial development.

Year:

2025

Organ shortage remains a major challenge in transplantation medicine. Interspecies blastocyst complementation is a promising approach to generate human organs in livestock hosts. However, getting xenogeneic donor cells to engraft and expand at early stages remains challenging. Here we identify an innate immune barrier, wherein host macrophages selectively recognize and eliminate viable xenogeneic donor cells. These events represent a form of phagoptosis and highlight a xenogeneic clearance process that we term xenophagocytosis. We identify the mechanism by which host macrophages selectively phagocytize xenogeneic donor cells: xenogeneic cells display elevated phosphatidylserine, an “eat-me” signal recognized by host macrophages through phagocytic receptor Axl. Xenophagocytosis blockade improves both rat and human donor chimerism in mouse embryos, indicating a conserved mechanism. These findings reveal potential mechanisms by which innate immune cells eliminate xenogeneic cells in early embryogenesis to preserve species integrity and offer improved strategies for generating human organs in livestock.

Year:

2025

The generation of human organs in animals through blastocyst complementation offers a promising solution to the shortage of transplantable organs. While human pluripotent stem cells (hPSCs) can contribute to interspecies chimaeric embryos when injected into preimplantation embryos of mice, pigs, or monkeys, their integration is often limited due to low chimaerism and segregation from host tissues, significantly impeding progress toward exogenic organ generation. Here, we demonstrate that co-overexpression of the anti-apoptotic gene BCL2 and the proto-oncogene MYCL , along with various cell cycle regulators significantly enhances human cell chimaerism by promoting cell proliferation. This strategy facilitates the generation of viable mouse pups containing hPSC-derived tissues without tumorigenesis. scRNA-seq analysis revealed that hPSCs already exit pluripotent by early post-implantation stage yet hPSCs with enhanced proliferation were able to integrate effectively into the cardiomyocytes and vasculature of both embryonic and extraembryonic tissues with gene expression profiles reflecting their structural integration. These findings highlight the critical role of cell cycle regulation in overcoming xenogeneic barriers. Our findings offer new insights into strategies for enhancing interspecies organogenesis and advancing the field of regenerative medicine. Highlight Enhancing hPSC proliferation increases human cell contribution in interspecies chimaeras Achieving the generation of viable human-mouse chimaeras without tumour formation hPSCs in post-implantation mouse epiblast exit pluripotency but retain the capacity to integrate into mouse embryogenesis hPSCs derivatives integrate into vasculature and cardiac tissues with lineage-matched transcriptional profiles

Year:

2025

Year:

2024

Autologous skin grafting is a standard treatment for skin defects such as burns. No artificial skin substitutes are functionally equivalent to autologous skin grafts. The cultured epidermis lacks the dermis and does not engraft deep wounds. Although reconstituted skin, which consists of cultured epidermal cells on a synthetic dermal substitute, can engraft deep wounds, it requires the wound bed to be well-vascularized and lacks skin appendages. In this study, we successfully generate complete skin grafts with pluripotent stem cell-derived epidermis with appendages on p63 knockout embryos’ dermis. Donor pluripotent stem cell-derived keratinocytes encroach the embryos’ dermis by eliminating p63 knockout keratinocytes based on cell-extracellular matrix adhesion mediated cell competition. Although the chimeric skin contains allogenic dermis, it is engraftable as long as autologous grafts. Furthermore, we could generate semi-humanized skin segments by human keratinocytes injection into the amnionic cavity of p63 knockout mice embryos. Niche encroachment opens the possibility of human skin graft production in livestock animals.

Year:

2024

Collaborators (8)

Jennifer Nichols

Professor of Embryonic Pluripotency; Principal Investigator and Academic Leader of Transgenics Facility

The University of Edinburgh MRC Human Genetics Unit

UNITED KINGDOM
View details

Hiroshi Nagashima

Meiji University

JAPAN
View details

Masashi Miyauchi

Staff Scientist

Stanford University

UNITED STATES
View details

Joydeep Bhadury

Senior Research Scientist

Stanford University

UNITED STATES
View details

Hiromitsu Nakauchi

Distinguished Professor

Tokyo Medical and Dental University

JAPAN
View details

Kevin Chalut

Group Leader

University of Cambridge

UNITED KINGDOM
View details

Hideki Masaki

Specially appointed Associate Professor

Tokyo Institute of Technology

JAPAN
View details

Eiji Mizutani

Associate Professor

University of Tsukuba

JAPAN
View details